摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(1-phenyl-2-propenyl)-4-methoxybenzylamine

中文名称
——
中文别名
——
英文名称
N-(1-phenyl-2-propenyl)-4-methoxybenzylamine
英文别名
N-[(4-methoxyphenyl)methyl]-1-phenylprop-2-en-1-amine
N-(1-phenyl-2-propenyl)-4-methoxybenzylamine化学式
CAS
——
化学式
C17H19NO
mdl
——
分子量
253.344
InChiKey
KESVLELACHTZJA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    21.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(1-phenyl-2-propenyl)-4-methoxybenzylamineRuCl2(1,3-dimesityl-imidazolidin-2-yl)(PCy3)(=CHPh)二异丁基氢化铝 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 正己烷二氯甲烷甲苯 为溶剂, 反应 88.0h, 生成 4-fluoro-1-[(4-methoxyphenyl)methyl]-2-phenyl-1H-pyrrole
    参考文献:
    名称:
    灵活合成多官能化的3-氟吡咯†
    摘要:
    从商业醛开始,已经开发了一种有效且选择性的合成多官能化3-氟吡咯的方法。该方法简明,有效并且允许模块化和系统地组装多取代的3-氟吡咯。这种合成为生成这些化学和生物学上重要的单元提供了另一种且高度收敛的策略。
    DOI:
    10.1039/c5ob02155c
  • 作为产物:
    描述:
    参考文献:
    名称:
    铱-亚磷酰胺络合物催化的非手性烯丙基酯的区域和对映选择性烯丙基胺化
    摘要:
    通过探索手性亚磷酰胺的配合物,开发了一种新的催化不对称过程,即铱催化的 (E)-肉桂基和末端脂肪族烯丙基碳酸酯的对映选择性烯丙基胺化。该反应以高产率提供支链仲胺和叔烯丙胺,具有出色的区域选择性和对映选择性(13 个实例超过 94% ee)。尽管在极性溶剂如 DMF、EtOH 和 MeOH 中的反应速度很快,但它们的对映体过量率很低。相比之下,THF 中的反应显示出最合适的速率和对映选择性平衡。亚磷酰胺中的联萘单元和二取代胺均影响反应性和选择性,以及 O,O'-(R)-(1,1'-二萘基-2,2'-二基)-N,N'-di 的配合物-(R, R)-1-苯基乙基亚磷酰胺提供了最高的反应性和选择性。伯胺和环状仲胺在室温下反应,无环二乙胺在 50 摄氏度下反应。对甲氧基取代的肉桂基碳酸酯与未取代的肉桂基碳酸酯的反应类似,但邻甲氧基取代的底物产生较低的对映体过量。对于呋喃基-和烷基-取代的(E)-烯丙基碳酸酯反应的产物,也观察到高ee。
    DOI:
    10.1021/ja028614m
点击查看最新优质反应信息

文献信息

  • Enantioselective amination and etherification
    申请人:Hartwig F John
    公开号:US20060199728A1
    公开(公告)日:2006-09-07
    The present invention is directed to a catalyst composition, comprising: (1) a catalyst precursor having the general structure MSX n wherein M is a transition metal selected from the group consisting of iridium, molybdenum, and tungsten; S is a coordinating ligand; X is a counterion; and n is an integer from 0 to 5; and (2) a phosphoramidite ligand having the structure wherein O—C n —O is an aliphatic or aromatic diolate and wherein R 1 , R 2 , R 3 and R 4 are selected from the group consisting of substituted or unsubstituted aryl groups, substituted or unsubstituted heteroaryl groups, substituted or unsubstituted aliphatic groups, and combinations thereof, with the proviso that at least one of R 1 , R 2 , R 3 , or R 4 must be a substituted or unsubstituted aryl or heteroaryl group. The present invention is also directed to activated catalysts made from the above catalyst composition, as well as methods of allylic amination and etherification using the above catalysts.
    本发明涉及一种催化剂组合物,包括:(1)具有一般结构MSXn的催化剂前体,其中M是从铱、钼和钨组成的过渡金属中选择的;S是一个配位配体;X是一个计数离子;n是从0到5的整数;以及(2)具有以下结构的磷酰胺配体,其中O-Cn-O是脂肪族或芳香族二醇,其中R1、R2、R3和R4选自取代或未取代的芳基基团、取代或未取代的杂环基团、取代或未取代的脂肪基团和它们的组合,但至少有一个R1、R2、R3或R4必须是取代或未取代的芳基或杂环基团。本发明还涉及由上述催化剂组合物制备的活性催化剂,以及使用上述催化剂进行烯丙基胺化和醚化的方法。
  • Enantioselective Phosphoramidite Compounds and Catalysts
    申请人:Hartwig F. John
    公开号:US20070259774A1
    公开(公告)日:2007-11-08
    This invention relates to phosphoramidite compounds and catalyst complexes which can be used to provide enantioselective reactions including hydroamination reactions, etherification reactions and conjugate addition reactions and allylic substitution reactions, among others. In a first aspect, the present invention is directed to phosphoramidite and related compounds according to general structure (I), where Z is absent or is a group containing O, N or S, preferably O; R 1 and R 2 are independently an optionally substituted C 1-12 alkyl group, an optionally substituted (CH 2 ) n -aromatic group or (CH 2 ) n -heteroaromatic group, or are linked together to form an optionally substituted aliphatic or (CH 2 ) n -aromatic dianion of a diol, diamine, dithiol, aminoalcohol, aminohiolate or a alcoholthiol group; R 3′ and R 3 are each independently H, an optionally substituted C 1 -C 12 alkyl group or an optionally substituted (CH 2 ) n -aromatic group with the proviso that R 3′ and R 3 are not both H, or together R 3′ and R 3 form an optionally substituted C 5 -C 15 saturated or unsaturated carbocyclic ring; R 4 is H, an optionally substituted C 1 -C 12 alkyl group or an optionally substituted (CH 2 ) n -aromatic group; R 5 is absent, H, an optionally substituted C 1 -C 12 alkyl group or an optionally substituted (CH 2 ) n -aromatic or (CH 2 ) n -heteroaromatic group; R a and R a′ are each independently H or a C 1 -C 3 alkyl group, or R a and R a′ together with the carbon to which they are attached form a optionally substituted C 5 -C 15 saturated or unsaturated carbocyclic or heterocyclic ring, or an aromatic or heteroaromatic ring; R 6 and R 7 are each independently H, an optionally substituted C 1 -C 12 alkyl group or an optionally substituted (CH 2 ) n -aromatic group, with the proviso that R 5 , R 6 and R 7 cannot simultaneously be H, and when R a and R a′ , together with the carbon to which they are attached, form a carbocyclic ring, heterocyclic ring or an aromatic or heteroaromatic ring, R 5 is absent or is preferably H; R 6 and R 7 are preferably H or CH 3 ; and each n is independently 0, 1, 2, 3, 4, 5 or 6 and wherein at least one of the carbon atoms attached to the nitrogen of the phosphoramidite group is a chiral center.
    本发明涉及磷酰胺类化合物和催化剂复合物,可用于提供对映选择性反应,包括羟胺化反应、醚化反应和共轭加成反应以及联烯取代反应等。在第一个方面,本发明涉及磷酰胺和相关化合物,其一般结构如下(I),其中Z不存在或是包含O、N或S的基团,优选为O;R1和R2分别为可选取代的C1-12烷基、可选取代的(CH2)n-芳基或(CH2)n-杂芳基,或相互连接形成可选取代的脂肪族或(CH2)n-芳香基的二阴离子的二元醇、二胺、二硫醇、氨基醇、氨基硫醇或醇硫基基团;R3'和R3各自独立地为H、可选取代的C1-C12烷基或可选取代的(CH2)n-芳基,但须满足R3'和R3不能同时为H,或者R3'和R3共同形成可选取代的C5-C15饱和或不饱和的碳环;R4为H、可选取代的C1-C12烷基或可选取代的(CH2)n-芳基;R5不存在、为H、可选取代的C1-C12烷基或可选取代的(CH2)n-芳基或(CH2)n-杂芳基;Ra和Ra'各自独立地为H或C1-C3烷基,或者Ra和Ra'与它们附着的碳共同形成可选取代的C5-C15饱和或不饱和的碳环或杂环,或芳香或杂芳环;R6和R7各自独立地为H、可选取代的C1-C12烷基或可选取代的(CH2)n-芳基,但须满足R5、R6和R7不能同时为H,且当Ra和Ra'与它们附着的碳共同形成碳环、杂环或芳香或杂芳环时,R5不存在或优选为H;R6和R7优选为H或CH3;每个n独立地为0、1、2、3、4、5或6,其中至少有一个连接到磷酰胺基团氮上的碳原子是手性中心。
  • US7732365B2
    申请人:——
    公开号:US7732365B2
    公开(公告)日:2010-06-08
  • [EN] ENANTIOSELECTIVE AMINATION AND ETHERIFICATION___________________<br/>[FR] AMINATION ET ETHERIFICATION ENANTIOSELECTIVE
    申请人:UNIV YALE
    公开号:WO2004024684A2
    公开(公告)日:2004-03-25
    The present invention is directed to a catalyst composition, comprising: (1) a catalyst precursor having the general structure MSXn wherein M is a transition metal selected from the group consisting of iridium, molybdenum, and tungsten; S is a coordinating ligand; X is a counterion; and n is an integer from 0 to 5; and (2) a phosphoramidite ligand having the structure wherein O-Cn-O is an aliphatic or aromatic diolate and wherein R1, R2, R3 and R4 are selected from the group consisting of substituted or unsubstituted aryl groups, substituted or unsubstituted heteroaryl groups, substituted or unsubstituted aliphatic groups, and combinations thereof, with the proviso that at least one of R1, R2, R3, or R4 must be a substituted or unsubstituted aryl or heteroaryl group. The present invention is also directed to activated catalysts made from the above catalyst composition, as well as methods of allylic amination and etherification using the above catalysts.
  • Regio- and Enantioselective Allylic Amination of Achiral Allylic Esters Catalyzed by an Iridium−Phosphoramidite Complex
    作者:Toshimichi Ohmura、John F. Hartwig
    DOI:10.1021/ja028614m
    日期:2002.12.1
    asymmetric process, the iridium-catalyzed enantioselective allylic amination of (E)-cinnamyl and terminal aliphatic allylic carbonates, was developed by exploring complexes of chiral phosphoramidites. The reaction provided branched secondary and tertiary allylic amines in high yields with excellent regio- and enantioselectivity (13 examples over 94% ee). Although the reactions in polar solvent such as
    通过探索手性亚磷酰胺的配合物,开发了一种新的催化不对称过程,即铱催化的 (E)-肉桂基和末端脂肪族烯丙基碳酸酯的对映选择性烯丙基胺化。该反应以高产率提供支链仲胺和叔烯丙胺,具有出色的区域选择性和对映选择性(13 个实例超过 94% ee)。尽管在极性溶剂如 DMF、EtOH 和 MeOH 中的反应速度很快,但它们的对映体过量率很低。相比之下,THF 中的反应显示出最合适的速率和对映选择性平衡。亚磷酰胺中的联萘单元和二取代胺均影响反应性和选择性,以及 O,O'-(R)-(1,1'-二萘基-2,2'-二基)-N,N'-di 的配合物-(R, R)-1-苯基乙基亚磷酰胺提供了最高的反应性和选择性。伯胺和环状仲胺在室温下反应,无环二乙胺在 50 摄氏度下反应。对甲氧基取代的肉桂基碳酸酯与未取代的肉桂基碳酸酯的反应类似,但邻甲氧基取代的底物产生较低的对映体过量。对于呋喃基-和烷基-取代的(E)-烯丙基碳酸酯反应的产物,也观察到高ee。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐